isotretinoin
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
2054
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
September 25, 2026
The effect of topical insulin in the treatment of isotretinoin-associated dry eye disease in patients with acne vulgaris.
(PubMed, Int Ophthalmol)
- "TI may represent a potentially useful therapeutic option for isotretinoin-associated dry eye disease."
Journal • Retrospective data • Acne Vulgaris • Dermatology • Dry Eye Disease • Ophthalmology
September 24, 2026
Best Practices for Managing Pseudofolliculitis Barbae: An Expert Consensus Delphi Study.
(PubMed, JAMA Dermatol)
- "No agreement was reached regarding a standardized grading scale, the use of oral isotretinoin for refractory disease, superficial chemical peels, or the use of multiblade razors. Using a Delphi consensus study approach, expert consensus guidelines were established for diagnosing and managing PFB. These recommendations provide an evidence-informed framework to support clinical decision-making, guide future research efforts, and help inform policy considerations associated with PFB management."
Journal • Aesthetic Medicine • Inflammation
September 23, 2026
FACEMICRO: Facial Skin Microbiome in Patients With Moderate-to-Severe Acne Vulgaris Treated With Isotretinoin
(clinicaltrials.gov)
- P=N/A | N=90 | Recruiting | Sponsor: Can Tho University of Medicine and Pharmacy
New trial • Acne Vulgaris • Dermatology
September 21, 2026
Physician Understanding and Perceptions of Risk Communication Related to Drugs Covered by Risk Evaluation and Mitigation Strategy Programs.
(PubMed, Pharmacoepidemiol Drug Saf)
- "While physicians largely expressed awareness of REMS testing requirements and found REMS programs to be valuable sources of risk communication, they would like more information on managing side effects, more accessible information on REMS requirements, integration of REMS programs with EMRs, and timely updates to REMS materials as new safety information emerges."
Journal
June 29, 2026
What's new in the treatment of scars
(EADV 2026)
- "*Other Treatments: Treatments for acne scars include topical retinoids, oral isotretinoin with fractional ablative CO2 laser, botulinum toxin A for surgical scars, and emerging therapies like dupilumab for keloids. Various treatments, including imiquimod cream, radiation therapy, laser treatment, and others, have been shown to reduce keloid recurrence rates and improve scar appearance. Genetic differences between keloids and other scar types suggest targeted therapeutic approaches could be beneficial.Objectives:1. To appreciate differences between keloids and other scars.2."
Acne Vulgaris • Aesthetic Medicine • Fibrosis
September 23, 2026
Prospective Exploratory Evaluation of Audiovestibular Function in Patients Receiving Oral Isotretinoin Using Audiometry and Videonystagmography.
(PubMed, Turk Arch Otorhinolaryngol)
- "Selected VNG-based vestibular assessments, including spontaneous nystagmus, gaze, positional, and oculomotor testing, remained within normal limits throughout the study period. Within the limitations of this exploratory pilot study, short-term oral isotretinoin therapy did not demonstrate clinically significant abnormalities in audiometric measurements or selected VNG-based vestibular assessments."
Journal • Acne Vulgaris • Dermatology • Ophthalmology
September 23, 2026
Ethical Considerations of Mandated iPLEDGE Pregnancy Testing.
(PubMed, J Am Acad Dermatol)
- No abstract available
Journal • Dermatology
August 06, 2026
An Unusual Presentation of Unilateral Rosacea Mimicking Majocchi's Granuloma Successfully Treated with Isotretinoin
(EADV 2026)
- No abstract available
Dermatology • Rosacea
August 06, 2026
Acitretin versus Isotretinoin in Pustular Psoriasis: A Real-World Comparative Study
(EADV 2026)
- No abstract available
Clinical • Real-world • Real-world evidence • Dermatology • Immunology • Psoriasis • Pustular Psoriasis
August 06, 2026
Oral Isotretinoin as a Potent Adjuvant to Azole Antifungals in Recalcitrant Dermatophytosis: A Case Series of 7 Patients
(EADV 2026)
- No abstract available
Clinical • Dermatology
August 06, 2026
Clinical Application of a Biomimetic Barrier-Repairing Lip Balm in Patients with Isotretinoin-Induced Cheilitis: A Case Series
(EADV 2026)
- No abstract available
Clinical
August 06, 2026
Off-label isotretinoin in refractory steatocystoma multiplex: sustained disease control and reduced procedural burden
(EADV 2026)
- No abstract available
August 06, 2026
Use of Oral Isotretinoin in the Management of Lichen Amyloidosis: A Case Report
(EADV 2026)
- No abstract available
Case report • Clinical • Amyloidosis
August 06, 2026
Beyond Standard Lipid Panels: Elevated Lipoprotein(a) in Young Adults with Prior Isotretinoin Exposure
(EADV 2026)
- No abstract available
Clinical
August 06, 2026
Combination of low-dose isotretinoin and 1450 nm non-ablative laser in moderate acne: a synergistic approach with reduced systemic burden
(EADV 2026)
- No abstract available
Acne Vulgaris
August 06, 2026
Concomitant Therapy of Oral Isotretinoin with Multiplex Pulsed Dye Laser and Nd: YAG Laser for Acne.
(EADV 2026)
- No abstract available
Acne Vulgaris
August 06, 2026
Treatment Success and Clinical Improvement Outcomes with Low-Dose Micronized Isotretinoin in Severe Recalcitrant Nodular Facial Acne: A Post Hoc Analysis of a Real-World Retrospective Electronic Medical Record-based Study
(EADV 2026)
- No abstract available
Real-world • Real-world evidence • Retrospective data • Acne Vulgaris
August 06, 2026
Assessing maternofetal risk associated with isotretinoin use preceding pregnancy: A retrospective cohort study
(EADV 2026)
- No abstract available
Retrospective data • Acne Vulgaris • Dermatology • Dermatopathology • Hidradenitis Suppurativa • Immunology
August 06, 2026
Evolution of olfactory function and associated factors in acne patients receiving oral isotretinoin: a longitudinal study
(EADV 2026)
- No abstract available
Clinical • Longitudinal study • Observational data • Acne Vulgaris
August 06, 2026
Effects of oral omega-3 fatty acids on isotretinoin tolerability in acne vulgaris: A systematic review and meta-analysis
(EADV 2026)
- No abstract available
Retrospective data • Review • Acne Vulgaris • Dermatology
August 06, 2026
Oral isotretinoin plus desloratadine for acne vulgaris: an updated global meta-analysis of efficacy, safety, and patient-centered outcomes
(EADV 2026)
- No abstract available
Retrospective data • Acne Vulgaris • Dermatology
August 06, 2026
Optimizing Isotretinoin Prescribing Safety: An AI-Driven Acne Assessment Model Integrating Lesion Staging with Atopic Dermatitis Risk Stratification
(EADV 2026)
- No abstract available
Clinical • Acne Vulgaris • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
August 06, 2026
Platform and positive sentiment are associated with higher engagement per view in isotretinoin-related videos: a cross-sectional analysis
(EADV 2026)
- No abstract available
Acne Vulgaris • Dermatology • Dermatopathology • Hidradenitis Suppurativa • Immunology
August 06, 2026
Cumulative isotretinoin dosing (120 vs 150 mg/kg) and 12-month relapse in acne vulgaris: a randomized controlled trial
(EADV 2026)
- No abstract available
Clinical • Acne Vulgaris • Dermatology
August 06, 2026
Effectiveness and Tolerability of Low-Dose Micronized Isotretinoin in Severe Recalcitrant Nodular Facial Acne: A Severity-Stratified Analysis of a Real-World Retrospective Electronic Medical Record-based Study
(EADV 2026)
- No abstract available
Real-world • Real-world evidence • Retrospective data • Acne Vulgaris
1 to 25
Of
2054
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83